Zaixin Yu

2.4k total citations
75 papers, 1.4k citations indexed

About

Zaixin Yu is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Zaixin Yu has authored 75 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 27 papers in Cardiology and Cardiovascular Medicine and 19 papers in Molecular Biology. Recurrent topics in Zaixin Yu's work include Pulmonary Hypertension Research and Treatments (26 papers), Coronary Interventions and Diagnostics (8 papers) and Vascular Anomalies and Treatments (7 papers). Zaixin Yu is often cited by papers focused on Pulmonary Hypertension Research and Treatments (26 papers), Coronary Interventions and Diagnostics (8 papers) and Vascular Anomalies and Treatments (7 papers). Zaixin Yu collaborates with scholars based in China, United States and Italy. Zaixin Yu's co-authors include Lihuang Zha, Tangzhiming Li, Lin Zhao, Jingni He, Qiangqiang Qi, Zhi‐Cheng Jing, Xin Jiang, Lei Pan, Xiaohui Li and Hui Luo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Zaixin Yu

72 papers receiving 1.4k citations

Peers

Zaixin Yu
Ankit A. Desai United States
Barend Mees Netherlands
Jose Gomez‐Arroyo United States
Zaixin Yu
Citations per year, relative to Zaixin Yu Zaixin Yu (= 1×) peers Sandrine Placier

Countries citing papers authored by Zaixin Yu

Since Specialization
Citations

This map shows the geographic impact of Zaixin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zaixin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zaixin Yu more than expected).

Fields of papers citing papers by Zaixin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zaixin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zaixin Yu. The network helps show where Zaixin Yu may publish in the future.

Co-authorship network of co-authors of Zaixin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zaixin Yu. A scholar is included among the top collaborators of Zaixin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zaixin Yu. Zaixin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Lin, Wenchao, Yiyang Tang, Tangzhiming Li, et al.. (2024). Selenium supplementation elevated SELENBP1 to inhibit fibroblast activation in pulmonary arterial hypertension. iScience. 27(10). 111036–111036. 5 indexed citations
5.
Chen, Yundai, Lei Gao, Qin Qin, et al.. (2024). Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trial. EuroIntervention. 20(13). e806–e817. 10 indexed citations
6.
Luo, Hui, et al.. (2023). Novel lncRNA LNC_000113 Drives the Activation of Pulmonary Adventitial Fibroblasts through Modulating PTEN/Akt/FoxO1 Pathway. Journal of Cardiovascular Development and Disease. 10(6). 262–262. 2 indexed citations
7.
Xie, Feng, Gangcheng Zhang, Yucheng Chen, et al.. (2023). Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry. The Journal of Heart and Lung Transplantation. 42(7). 974–984. 5 indexed citations
8.
Chen, Xiaoxi, Gangcheng Zhang, Yuanhua Yang, et al.. (2023). Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study. ERJ Open Research. 9(6). 495–2023. 1 indexed citations
9.
Chen, Xiaoxi, Zhenwen Yang, Zaixin Yu, et al.. (2023). 10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry. Lara D. Veeken. 62(11). 3555–3564. 12 indexed citations
10.
Zeng, Xiaofang, Qiong Liu, Anandharajan Rathinasabapathy, et al.. (2023). Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report. BMC Pulmonary Medicine. 23(1). 26–26. 3 indexed citations
11.
Chen, Xiaoxi, Qing Gu, Changming Xiong, et al.. (2022). Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China. CHEST Journal. 163(6). 1531–1542. 8 indexed citations
12.
Tang, Yiyang, Xiaofang Zeng, Yilu Feng, et al.. (2021). Association of Systemic Immune-Inflammation Index With Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study. Frontiers in Cardiovascular Medicine. 8. 753133–753133. 71 indexed citations
13.
Zeng, Xiaofang, Anandharajan Rathinasabapathy, Xihui Xu, et al.. (2021). BECLIN 1 KNOCKDOWN ATTENUATED HIGH FATTY DIET-INDUCED CARDIOMYOPATHY BY ACTIVATING RAB9-DEPENDENT ALTERNATIVE AUTOPHAGY PATHWAY. Journal of the American College of Cardiology. 77(18). 767–767. 2 indexed citations
14.
Zha, Lihuang, et al.. (2020). NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation. Oxidative Medicine and Cellular Longevity. 2020. 1–14. 20 indexed citations
15.
Tang, Yiyang, Lihuang Zha, Xiaofang Zeng, & Zaixin Yu. (2020). Identification of Biomarkers Related to Systemic Sclerosis With or Without Pulmonary Hypertension Using Co-expression Analysis. Journal of Computational Biology. 27(10). 1519–1531. 6 indexed citations
16.
Zhao, Lin, Hui Luo, Xiaohui Li, et al.. (2017). Exosomes Derived from Human Pulmonary Artery Endothelial Cells Shift the Balance between Proliferation and Apoptosis of Smooth Muscle Cells. Cardiology. 137(1). 43–53. 65 indexed citations
17.
Luo, Hui, Bin Liu, Lin Zhao, et al.. (2017). Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension. Journal of the American Society of Hypertension. 11(10). 673–683.e3. 32 indexed citations
18.
Jing, Zhi‐Cheng, Zaixin Yu, Jieyan Shen, et al.. (2011). Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study. American Journal of Respiratory and Critical Care Medicine. 183(12). 1723–1729. 138 indexed citations
19.
Shen, Wen‐Jun, et al.. (2006). Effects of rosiglitazone and high fat diet on lipase/esterase expression in adipose tissue. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1771(2). 177–184. 37 indexed citations
20.
Yu, Zaixin, Hideo Tamai, Eisho Kyo, et al.. (2002). Comparison of the self‐expanding Radius stent and the balloon‐expandable Multilink stent for elective treatment of coronary stenoses: A serial analysis by intravascular ultrasound. Catheterization and Cardiovascular Interventions. 56(1). 40–45. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026